Cas:6737-68-4 1,4-bis(2-methylanilino)anthracene-9,10-dione manufacturer & supplier

Chemical Name:1,4-bis(2-methylanilino)anthracene-9,10-dione

CAS.NO:6737-68-4

Synonyms:1,4-Bis(2-methylanilino)anthraquinone;1,4-di-o-toluidino-anthraquinone;disperse maroon II;1,4-Bis((2-methylphenyl)amino)anthraquinone;1,4-Di-o-toluidino-anthrachinon;Solvent Blue 101,Technical grade;9,10-Anthracenedione,1,4-bis[(2-methylphenyl)amino];EINECS 229-792-8

Molecular Formula:C₂₈H₂₂N₂O₂

Molecular Weight:418.48600

HS Code:2922399090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:612ºC at 760 mmHg

Density:1.292

Index of Refraction:1.714

PSA:58.20000

Exact Mass:418.16800

LogP:6.71200

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1,4-Bis(2-methylanilino)anthraquinone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,EINECS 229-792-8 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,4-Bis((2-methylphenyl)amino)anthraquinone Use and application,1,4-di-o-toluidino-anthraquinone technical grade,usp/ep/jp grade.

Related News: Under the sub-licensing agreement, Mankind will market the drug under its own trademark while Glenmark will manufacture and supply it to the drug firm. 1,4-bis(2-methylanilino)anthracene-9,10-dione manufacturer Characteristic APIs represented by cardiovascular, antiviral, antitumor and other categories are targeted at generic APIs with patent expiring original research drugs, which have high scientific and technological content and rich profits. They have developed in China in the past decade. The more active API segment has contributed to the rise of Huahai Pharmaceutical, Chuangnuo Pharmaceutical, and Jiangbei Pharmaceutical. 1,4-bis(2-methylanilino)anthracene-9,10-dione supplier At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth. 1,4-bis(2-methylanilino)anthracene-9,10-dione vendor At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth. 1,4-bis(2-methylanilino)anthracene-9,10-dione factory Under the sub-licensing agreement, Mankind will market the drug under its own trademark while Glenmark will manufacture and supply it to the drug firm.